PCR techniques have paved the way for innovation in life sciences research and molecular diagnostics through its most potential features such as absolute detection and quantification of genetic materials such as DNA and RNA. Researchers are able to quantify and analyze rare alleles and point mutations using advanced PCR systems such as digital PCR. Currently, the market players are engaged in developing PCR systems with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity. Other major advances associated with the PCR include shorter turnaround times (PCR cycling time), higher productivity and automated workflow; thereby ensuring efficient detection and amplification of genetic materials with accurate results. The market is witnessing significant advances in the design of PCR platforms shifting from conventional standard PCR to real time and digital PCR systems to efficiently detect pathogenic microbes such as mycobacterium tuberculosis bacteria and influenza viruses. For instance, introduction of QX200 Droplet Digital PCR System by Bio-Rad provides a broad menu of molecular diagnostic tests and enhanced workflow to enable overall cost reduction and eliminate the need for multiple systems. The global PCR market is valued at USD 6,065 million in 2013 and is expected to reach USD 9,621.0 million with the CAGR of 6.6% during the forecast period of 2014 to 2020.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830
The report studies the worldwide PCR market on the basis of product, application, end use, and the regional distribution of this market. Based on product, the market has been classified into instruments and reagents and consumables. The reagents and consumables segment led the global PCR market with a share of 67%, amounting to US$4 bn in 2013.
By application, the market has been categorized into clinical diagnostics, life sciences, and other application. The life sciences segment dominated the global PCR market with a share of 48% in 2013.
By end use, the report segments the global PCR market into clinical diagnostics labs and hospitals, academic and research organizations, and the pharmaceutical and biotechnology industries. In 2013, the academics and research organizations segment emerged as the biggest end user of polymerase chain reactions across the world, says the study.
Regionally, the report divides the global PCR market into North America, Asia Pacific, Europe, and the Rest of the World. Among these, North America emerged as the leading regional market in 2013 with a total value of US$2.6 bn. Analysts project it to reach a value of US$3.9 bn by the end of the forecast period. Asia Pacific, on the other hand, is estimated to register the highest growth rate among all the regional markets over the forecast period, states the report.
The study reports that the worldwide PCR market is concentrated in nature. Sigma-Aldrich Co., F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., Becton, Dickinson & Co., Affymetrix Inc., Bio-Rad Laboratories Inc., GE Healthcare, Abbott Laboratories, QIAGEN, Thermo Fisher Scientific Inc., and Agilent Technologies Inc. are some of the key market participants mentioned in this report.